Physician

Fadi Deeb, MD

According to 2025 Medicare claims, Fadi Deeb, MD (NPI: 1497729248) practices gastroenterology in the Sierra Vista-Douglas, AZ market, with the plurality of this provider's patient population coming from Cochise, AZ. This provider's primary affiliated billing organization is SWAN GASTROENTEROLOGY, P.C. (NPI: 1619368891; TIN: 454004946) and primary practice location at 85635-2530. Deeb is affiliated with the Abacus Health LLC (ACO ID: A2811) and Equality Health ACO, LLC (ACO ID: A5515), participating under the MSSP model.

Deeb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 774 traditional Medicare patients, billed 1,320 HCPCS/CPT codes, and received $177,595 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,125 prescription claims across 536 beneficiaries totaling $278,818 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 94 records totaling $572,179. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $212,666 and ending at $177,595. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $552,496 to $278,818. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	509	1,969	$212,666
2016	508	1,878	$199,520
2017	630	2,392	$249,797
2018	566	1,797	$200,896
2019	480	1,511	$180,265
2020	461	1,422	$153,243
2021	813	2,100	$270,770
2022	804	1,695	$238,044
2023	751	1,294	$221,244
2024	774	1,320	$177,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	451	1,277	$552,496
2016	466	1,236	$891,699
2017	434	1,106	$1,132,380
2018	447	923	$510,406
2019	457	982	$206,975
2020	466	1,028	$399,283
2021	483	1,092	$368,221
2022	459	1,124	$305,855
2023	493	1,121	$201,539
2024	536	1,125	$278,818

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	59	59	$170
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	106	110	$141
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	275	275	$112
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	111	111	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	212	277	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	12	336	$96,542
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	115	375	$18,922
Linzess	Linaclotide	15	1,050	$18,557
Mesalamine	Mesalamine	26	1,712	$5,710
Pantoprazole Sodium	Pantoprazole Sodium	461	31,735	$4,408

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	84	$1,965	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$570,215	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fadi Deeb, MD?

Tedicare shows public-source Medicare data for Fadi Deeb, MD (NPI 1497729248), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fadi Deeb, MD have ACO affiliation data?

Fadi Deeb, MD is shown with ACO affiliation data for Abacus Health LLC (MSSP, ACO ID A2811) and Equality Health ACO, LLC (MSSP, ACO ID A5515).

What billing organization is linked to Fadi Deeb, MD?

Fadi Deeb, MD is linked to SWAN GASTROENTEROLOGY, P.C. (billing NPI 1619368891) in the available physician profile data.

Does Fadi Deeb, MD have Open Payments data?

Fadi Deeb, MD has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.